A Study of [177Lu]Lu-A9-0631 and [225Ac]Ac-A9-0642 With [68Ga]Ga-A9-6217 or [177Lu]Lu-A9-0631 Imaging in GRPR+ Solid Tumors

Clinical trial NCT07661641 · RECRUITING

Trial details

NCT number: NCT07661641
Sponsor: Alpha-9 Oncology USA Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Breast Cancer Prostate Cancer Colorectal Cancer GRPR-positive Solid Tumors

Start date: 2026-07-01
Primary completion: 2028-12-01
Enrollment: 115

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.